Navigation Links
Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss
Date:3/4/2009

Unique Case Study of Patient Before & After mTBI Accident

Presentation at American Balance Society, Case Study on Web Site, New Help for Returning Vets

PITTSBURGH, March 4 /PRNewswire/ -- With record numbers of American soldiers returning from Iraq and Afghanistan with brain injuries, a case study from Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com) suggests that tests utilizing its I-Portal(R) NOTC (Neuro-Otologic Test Center) system can generate results that may indicate mild traumatic brain injuries (mTBI) that are not detected by other evaluation technologies.

NKI manufactures noninvasive medical test equipment used worldwide in the evaluation of balance, vestibular and neurological disorders.

The details of the new case study are available on NKI's Web site (http://www.neuro-kinetics.com/docs/Mild-Traumatic-Brain-Injury.pdf). The findings are being presented today at an American Balance Society conference in Scottsdale, AZ.

The paper's authors are Brian J. McKinnon, MD, MBA, assistant professor, Otology/Neurotology, Department of Otolaryngology-Head & Neck Surgery, Medical College of Georgia; Alex Kiderman, PhD, NKI's chief technology officer; and Terri E. Ives, ScD, AuD, F-AAA, CCC-A, NKI's clinical director - audiology.

The case study features unique pre- and post-accident neuro-otologic test data gathered from one individual, a NKI employee who had undergone various I-Portal NOTC evaluations as part of routine product testing and then again after he suffered a bicycle accident last year.

"The situation with our colleague presented us with a rare opportunity to evaluate a patient after an accident and then to compare those results to baseline data previously collected," explained Kiderman.

"Clinicians who deal with brain injuries will be intrigued by our findings. The I-Portal NOTC system collected data that appears to be able to indicate mild traumatic brain injuries that other evaluation methods missed," Kiderman said. "The patient in our study had undergone a CT scan after his accident, but those results were negative. The I-Portal NOTC's were not. The patient felt he was not healthy, and our results support that.

"We believe this case study may shed new light on how medical professionals can identify mild traumatic brain injuries and traumatic brain injuries," Kiderman added. "We are continuing our work in this vital area and hope that others will be encouraged by our results and will pursue additional research."

Specific tests conducted on the NKI employee before and after his accident and reported in the case study included optokinetic (OKN), spontaneous, pendular tracking, saccade, horizontal and vertical gaze, subjective visual vertical (SVV) and subjective visual horizontal (SVH), head thrust test (HTT), and sinusoidal harmonic acceleration test (SHA). The HTT test is currently investigational.

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, founded in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company's products include the I-Portal(R) NOTC System (Neuro-Otologic Test Center), I-Portal(R) VNG (Video Nystagmography) system and I-Portal(R) VOG (Video-Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.

    MEDIA CONTACT:
    John Buckman
    Buckman Communications
    412 381 2900
    jbuckman@buckman.biz


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
2. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
3. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
4. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
5. Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
8. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
9. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
10. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
11. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):